Latest Safety News

Elevra Lithium has completed a transformative merger and maintained robust production at its North American Lithium operation, while unveiling a compelling expansion plan that could boost output by 55% and slash costs.

Triangle Energy (Global) Limited has amended its quarterly cash flow report to correct key figures while advancing new permits in the Philippines and progressing the transition of its Cliff Head Oil Field to a carbon capture and storage project.

Truscott Mining Corporation advances exploration at Westminster and Barkly Projects, confirming new mineralised zones and refining structural models to guide targeted drilling. The company is also progressing site preparations and exploring funding options to support phased development.

Enterprise Metals reports encouraging preliminary gold assay results from its recent drilling at the Vulcan Prospect within the Doolgunna Project, highlighting significant near-surface mineralisation and potential for a substantial gold deposit.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Centaurus Metals has achieved a major milestone with the granting of the Jaguar Nickel Sulphide Project mining lease and reported promising new copper-gold discoveries at its Boi Novo project, underpinning its growth ambitions in Brazil.

Triangle Energy (Global) Limited has secured three new permits in the Philippines, advancing its gas exploration portfolio while navigating joint venture withdrawals in Australia and finalising the sale of its Cliff Head onshore assets.

Cycliq Group has completed a major e-commerce platform upgrade while preparing inventory for the critical Cyber November sales, reporting a 35% drop in quarterly customer receipts as it invests in future growth.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.

Nickel Industries reported a robust Q3 2025 with a 20% rise in RKEF EBITDA and a successful US$800 million debt refinancing, despite operational challenges at its Hengjaya Mine. The company also marked zero lost time injuries and advanced key projects toward production.

Anteris Technologies has enrolled the first patients in its pivotal PARADIGM Trial, testing the DurAVR Transcatheter Heart Valve against leading competitors in a global study.

Bathurst Resources reported a Q1 FY26 EBITDA of NZD 5.2 million, maintaining full-year guidance and progressing major development projects in New Zealand and Canada.